EB-47
CAS No. 366454-36-6
EB-47 ( —— )
产品货号. M26189 CAS No. 366454-36-6
EB-47 模拟底物 NAD+,并从烟酰胺延伸至腺苷亚位点。EB-47 是一种有效的选择性 PARP-1/ARTD-1 抑制剂,IC50 值为 45 nM。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1077 | 有现货 |
|
10MG | ¥1806 | 有现货 |
|
25MG | ¥3216 | 有现货 |
|
100MG | 获取报价 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称EB-47
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述EB-47 模拟底物 NAD+,并从烟酰胺延伸至腺苷亚位点。EB-47 是一种有效的选择性 PARP-1/ARTD-1 抑制剂,IC50 值为 45 nM。
-
产品描述EB-47 mimics the substrate NAD+ and extends from the nicotinamide to the adenosine subsite.EB-47, a potent and selective PARP-1/ARTD-1 inhibitor with an IC50 value of 45 nM, shows modest potency against ARTD5 with an IC50 value of 410 nM.(In Vitro):The inhibitory effect of EB-47 on CdPARP and HsPARP was 0.86 and 1.0uM with IC50 value respectively, and the inhibitory effect on CdPARP was over 50%.(In Vivo):EB-47 (2 μM;?5 days) decreases the number of embryo implantation sites and blastocysts at day 5.PARP1 participates in the process of embryo implantation.
-
体外实验EB-47 shows inhibition in excess of 50% with CdPARP, and it is able to inhibit CdPARP and HsPARP with IC50 values of 0.86 and 1.0?μM, respectively.
-
体内实验EB-47 (2 μM; 5 days) decreases the number of embryo implantation sites and blastocysts at day 5. PARP1 participates in the process of embryo implantation.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体5-HT1A| 5-HT2A| D2 receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number366454-36-6
-
分子量537.537
-
分子式C24H27N9O6
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESNc1ncnc2n(cnc12)[C@@H]1O[C@@H]([C@@H](O)[C@H]1O)C(=O)N1CCN(CC(=O)Nc2cccc3C(=O)NCc23)CC1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Jann MW, et al. Long-Acting Injectable Second-Generation Antipsychotics:An Update and Comparison Between Agents.CNS Drugs. 2018 Mar;32(3):241-257.
产品手册
关联产品
-
Suavissimoside F1
Suavissimoside F1 is a natural product.
-
Ethyl chrysanthemuma...
菊酸乙酯是一种用作引诱剂的化感化合物。
-
Anisic aldehyde
大茴香醛是一种天然存在的芳香酚类化合物,对念珠菌(包括唑类耐药菌株)具有显着的抗真菌活性。